Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2500
Single User License Price INR 168625
Corporate User License Price USD 7500
Corporate User License Price INR 505875
Site License Price USD 5000
Site License Price INR 337250
Request a Quote

Report Title

Fatty Liver Disease Global Clinical Trials Review, H1, 2015

Quote Request for License Type
License Type Price  
Single User License USD 2500
Site License USD 5000
Enterprise Wide License USD 7500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Fatty Liver Disease Global Clinical Trials Review, H1, 2015


Quote Request for License Type
License Type Price  
Single User License USD 2500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Fatty Liver Disease Global Clinical Trials Review, H1, 2015

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Fatty Liver Disease Global Clinical Trials Review, H1, 2015



Executive Summary

Fatty Liver Disease Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Fatty Liver Disease Global Clinical Trials Review, H1, 2015" provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fatty Liver Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Fatty Liver Disease 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Fatty Liver Disease 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Fatty Liver Disease Therapeutics Clinical Trials 31

Prominent Drugs 32

Latest Clinical Trials News on Fatty Liver Disease 33

Feb 24, 2015: Galectin Therapeutics Announces Details of the Design of Its Phase 2 Program With GR-MD-02 33

Clinical Trial Profiles 35

Clinical Trial Overview of Top Companies 35

AstraZeneca PLC 35

Clinical Trial Overview of AstraZeneca PLC 35

Galmed International Ltd. 36

Clinical Trial Overview of Galmed International Ltd. 36

F. Hoffmann-La Roche Ltd. 37

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37

DURECT Corporation 38

Clinical Trial Overview of DURECT Corporation 38

PharmaKing Co., Ltd. 39

Clinical Trial Overview of PharmaKing Co., Ltd. 39

Novo A/S 40

Clinical Trial Overview of Novo A/S 40

Merck & Co., Inc. 41

Clinical Trial Overview of Merck & Co., Inc. 41

GlaxoSmithKline plc 42

Clinical Trial Overview of GlaxoSmithKline plc 42

Abbott Laboratories 43

Clinical Trial Overview of Abbott Laboratories 43

Eli Lilly and Company 44

Clinical Trial Overview of Eli Lilly and Company 44

Clinical Trial Overview of Top Institutes / Government 45

Tabriz University of Medical Sciences 45

Clinical Trial Overview of Tabriz University of Medical Sciences 45

The National Institute of Diabetes and Digestive and Kidney Diseases 46

Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 46

Tehran University of Medical Sciences 47

Clinical Trial Overview of Tehran University of Medical Sciences 47

FUDAN University 48

Clinical Trial Overview of FUDAN University 48

University of Michigan 49

Clinical Trial Overview of University of Michigan 49

Ahvaz Jundishapur University of Medical Sciences 50

Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 50

Bambino Gesu Hospital and Research Institute 51

Clinical Trial Overview of Bambino Gesu Hospital and Research Institute 51

Third Military Medical University 52

Clinical Trial Overview of Third Military Medical University 52

Chinese University of Hong Kong 53

Clinical Trial Overview of Chinese University of Hong Kong 53

Hadassah Medical Organization 54

Clinical Trial Overview of Hadassah Medical Organization 54

Five Key Clinical Profiles 55

Appendix 80

Abbreviations 80

Definitions 80

Research Methodology 81

Secondary Research 81

About GlobalData 82

Contact Us 82

Disclaimer 82

Source 82

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Fatty Liver Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Fatty Liver Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Fatty Liver Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Fatty Liver Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Fatty Liver Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Fatty Liver Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Fatty Liver Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Fatty Liver Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Fatty Liver Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Fatty Liver Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Fatty Liver Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Fatty Liver Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Fatty Liver Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Fatty Liver Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Fatty Liver Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Fatty Liver Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Fatty Liver Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Fatty Liver Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Fatty Liver Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Fatty Liver Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 81

List of Tables

Fatty Liver Disease Therapeutics, Global, Clinical Trials by Region, 2015* 7

Fatty Liver Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Fatty Liver Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Fatty Liver Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Fatty Liver Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Fatty Liver Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Fatty Liver Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Fatty Liver Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15

Fatty Liver Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Fatty Liver Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Fatty Liver Disease to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18

Fatty Liver Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Fatty Liver Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Fatty Liver Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Fatty Liver Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Fatty Liver Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Fatty Liver Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Fatty Liver Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25

Fatty Liver Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 26

Fatty Liver Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Fatty Liver Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Fatty Liver Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Fatty Liver Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 35

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Galmed International Ltd., 2015* 36

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 37

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by DURECT Corporation, 2015* 38

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by PharmaKing Co., Ltd., 2015* 39

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 40

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 41

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 42

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 43

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 44

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2015* 45

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 46

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 47

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2015* 48

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2015* 49

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2015* 50

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Bambino Gesu Hospital and Research Institute, 2015* 51

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Third Military Medical University, 2015* 52

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 53

Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2015* 54

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Fatty Liver Disease Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Fatty Liver Disease, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand